arrow
P

Patricia Díez

university college london
H指数:12
被引数:950

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identifying high-risk components in online adaptive RT through a multi-centre FMEA to inform clinical trial QA needs

通过多中心FMEA识别在线自适应RT中的高风险组件以告知临床试验QA需求

2026-04-090
PRE
Royal College of Radiologists Guidance Statements on the Use of Auto-contouring in Radiotherapy

Mackay, K.; Banfill, K.; Bernstein, D.; Daniel, J.; Diez, P.; Gwynne, S.; Hoole, A.; Jena, R.; Marchant, T.; Nix, M.; et al. 英国皇家放射学院关于放射治疗中自动勾画轮廓使用的指导声明。Clin. Oncol. 2025, 50, 104004. [Google Scholar] [CrossRef]

2026-01-011
PRE
Establishing a national SABR service: A model for safe and effective clinical implementation

建立国家SABR服务:安全有效临床实施的一个模型

2025-11-270
PRE
Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers

重新定义前列腺癌精准医学:放射基因组学、治疗诊断学及人工智能驱动的生物标志物

2025-11-240
OAAI
Beyond Visualization: Advanced Imaging, Theragnostics and Biomarker Integration in Urothelial Bladder Cancer

超越可视化:高级成像、诊疗一体化及生物标志物整合在尿路上皮性膀胱癌中的应用

2025-10-080
OAAI
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3trial

局部晚期宫颈癌患者的诱导化疗后标准放化疗与单独标准放化疗 (GCIG INTERLACE): 一项国际多中心随机3期试验

LANCET
IF88.5
2024-10-014
OAAI
The STAMPEDE2 stereotactic ablative body radiotherapy (SABR) trial: A phase III, randomised, open-label trial in patients with newly diagnosed oligometastatic prostate cancer (PC) starting androgen deprivation therapy (ADT)

STAMPEDE2立体定向消融体部放射治疗(SABR)试验:一项针对新诊断寡转移性前列腺癌(PC)患者(开始接受雄激素剥夺治疗(ADT))的III期、随机、开放标签试验

2024-09-010
PRE
SEAFARER - A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practice
2022-06-0112
PRE